We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+27.44%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$6.27B
AUM Growth
+$1.32B
Cap. Flow
+$81.3M
Cap. Flow %
1.3%
Top 10 Hldgs %
29.27%
Holding
150
New
7
Increased
71
Reduced
48
Closed
5

Top Buys

Rank Stock Value
1
VERX icon
Vertex
VERX
+$70M
2
MODN
MODEL N, INC.
MODN
+$45.2M
3
CWST icon
Casella Waste Systems
CWST
+$18.2M
4
SLP icon
Simulations Plus
SLP
+$14.1M
5
AVLR
Avalara, Inc.
AVLR
+$6.87M

Top Sells

Rank Stock Value
1
TECH icon
Bio-Techne
TECH
+$42.1M
2
PRLB icon
Protolabs
PRLB
+$36.3M
3
RGEN icon
Repligen
RGEN
+$26.1M
4
WDFC icon
WD-40
WDFC
+$11.2M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$8.43M

Sector Composition

Rank Sector Weight
1 Technology 33.67%
2 Industrials 28.38%
3 Healthcare 17.2%
4 Consumer Discretionary 8.25%
5 Materials 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTNT icon
101
Fortinet
FTNT
$117B
$885K 0.01%
29,790
-775
-3% -$19.6K
MKL icon
102
Markel Group
MKL
$23.2B
$877K 0.01%
849
– –
COST icon
103
Costco
COST
$420B
$863K 0.01%
2,290
-60
-3% -$22.4K
ABBV icon
104
AbbVie
ABBV
$435B
$850K 0.01%
7,935
– –
XOM icon
105
ExxonMobil
XOM
$634B
$769K 0.01%
18,654
– –
MMM icon
106
3M
MMM
$94.3B
$724K 0.01%
4,951
-48
-1% -$6.81K
LIN icon
107
Linde
LIN
$226B
$702K 0.01%
2,665
-120
-4% -$29.5K
ROP icon
108
Roper Technologies
ROP
$39.8B
$690K 0.01%
1,600
-65
-4% -$26.7K
FDS icon
109
Factset
FDS
$10.2B
$687K 0.01%
2,066
-25
-1% -$8.26K
DLB icon
110
Dolby
DLB
$5.79B
$670K 0.01%
6,893
+525
+8% +$43.4K
PFE icon
111
Pfizer
PFE
$153B
$667K 0.01%
18,108
-345
-2% -$12.7K
IDXX icon
112
Idexx Laboratories
IDXX
$46.2B
$650K 0.01%
1,300
-75
-5% -$33.6K
VEEV icon
113
Veeva Systems
VEEV
$37.4B
$640K 0.01%
2,350
-100
-4% -$28K
INTU icon
114
Intuit
INTU
$89B
$634K 0.01%
1,670
-135
-7% -$47.4K
JNJ icon
115
Johnson & Johnson
JNJ
$625B
$602K 0.01%
3,826
-170
-4% -$25.1K
KMB icon
116
Kimberly-Clark
KMB
$36.5B
$573K 0.01%
4,250
– –
PG icon
117
Procter & Gamble
PG
$339B
$548K 0.01%
3,940
– –
GRMN
118
Garmin
GRMN
$60B
$547K 0.01%
4,570
– –
WCN
119
Waste Connections
WCN
$42B
$547K 0.01%
5,330
+745
+16% +$76.9K
MRK icon
120
Merck
MRK
$318B
$544K 0.01%
6,969
– –
ADBE icon
121
Adobe
ADBE
$105B
$543K 0.01%
1,085
-50
-4% -$24.2K
XYL icon
122
Xylem
XYL
$28.1B
$474K 0.01%
4,660
-320
-6% -$30.1K
SJM icon
123
J.M. Smucker
SJM
$12.8B
$464K 0.01%
4,015
-90
-2% -$10.5K
TRU icon
124
TransUnion
TRU
$15.3B
$406K 0.01%
4,090
+100
+3% +$9.15K
MA icon
125
Mastercard
MA
$493B
$403K 0.01%
1,130
-85
-7% -$28.3K
2 3 4
5
6

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $4.53B AUM 21.1% 1-Year Est. Return

Conestoga Capital Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Conestoga Capital Advisors held 150 positions worth $6.27B, up 27% from $4.96B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Conestoga Capital Advisors's Q4 2020 filing shows 7 new, 71 increased, 48 reduced and 5 closed positions. Its largest new stake was Vertex: 2,572,160 shares worth $89.6M. The largest sale was Bio-Techne, an estimated $42.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.

  • Conestoga Capital Advisors's largest Q4 2020 buy was Vertex: 2,572,160 shares worth $89.6M.
  • Conestoga Capital Advisors added most to MODEL N, INC. in Q4 2020, an estimated $45.2M increase.
  • Conestoga Capital Advisors's biggest Q4 2020 reduction was Bio-Techne, cutting an estimated $42.1M.
  • Conestoga Capital Advisors fully exited Protolabs in Q4 2020, selling an estimated $36.3M.
  • Conestoga Capital Advisors's ten largest holdings make up 29% of its $6.27B portfolio in Q4 2020.
  • Conestoga Capital Advisors opened 7 new positions and closed 5 in Q4 2020.
  • Conestoga Capital Advisors's portfolio value rose 27% quarter-over-quarter to $6.27B.

Based on Conestoga Capital Advisors's 13F filing for Q4 2020, filed 26 Jan 2021.